Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood Cancer Journal|June 17, 2025
A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM)Chandramouli Nagarajan, Wei-Ying Jen, Melissa Ooi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritisTed R Mikuls, Justin O Endo, Susan E Puumala, et al.
Blood|February 16, 2011
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implicationsJana Jakubikova, Sophia Adamia, Maria Kost-Alimova, et al.
Blood Cancer Journal|February 13, 2021
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaYunlu Jia, Jianbiao Zhou, Tze King Tan, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and managementMelinda Tan, Yunxin Chen, Melissa Ooi, et al.
Blood Cancer Journal|July 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in AsiaHarinder Gill, Rita Yim, Paul Lee, et al.
Targeted Oncology|April 15, 2023
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesCheng E Chee, Melissa Ooi, Soo-Chin Lee, et al.
Hematology/Oncology and Stem Cell Therapy|April 30, 2018
Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myelomaSanjay de Mel, Yunxin Chen, Adeline Lin, et al.
Pageof 4